Jefferies Upgrades GameStop (GME) to Buy; 'Cycle Trade Is On'

Go back to Jefferies Upgrades GameStop (GME) to Buy; 'Cycle Trade Is On'

GameStop (GME) PT Raised to $6 at Loop Capital

September 11, 2020 7:09 AM EDT

Loop Capital analyst Anthony Chukumba raised the price target on GameStop (NYSE: GME) to $6.00 (from $4.00) while maintaining a Hold rating.... More

GameStop (GME) PT Raised to $5.50 at Ascendiant Capital After Earnings

September 11, 2020 6:16 AM EDT

Ascendiant Capital analyst Edward Woo raised the price target on GameStop (NYSE: GME) to $5.50 (from $4.00) after the company reported a top and bottom line miss. Revenue of $942 million (-27% y-o-y), missed consensus expectations of $1.01 billion while EPS of $(1.40) also missed consensus of $(1.17). In Q1, the... More

Pre-Open Movers 09/10: (VRTU) (RH) (NAV) Higher; (STSA) (PRPL) (NKLA) Lower (more...)

September 10, 2020 9:32 AM EDT

Today's Pre-Open Movers

Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) 80% LOWER; announced topline results from its Phase 3 EMERGE efficacy trial of STS101 (dihydroergotamine (DHE) nasal) powder as an acute treatment for migraine. Although topline data showed numerical differences in favor of STS101 3.9 mg and 5.2 mg versus placebo on the pre-specified co-primary endpoints of freedom from pain and freedom from most bothersome symptom (from among photophobia, phonophobia and nausea) at two hours post-administration, these differences did not achieve statistical significance for either dosage strength. Both dosage strengths of STS101 did, however,... More

GameStop (GME) PT Raised to $7 at Jefferies

September 10, 2020 4:12 AM EDT

Jefferies analyst Stephanie Wissink raised the price target on GameStop (NYSE: GME) to $7.00 (from $5.00) while maintaining a Hold rating.... More